Q: Could I get you take on Viemed's latest earnings, please? I'm in at $7. Would you recommend I sell, hold or buy at these levels (looking long term)? Thank you.
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: In Jaime’s question he references GUD price to book, one has to realize that the acquisition was done at a premium to market, and likely several multiples above book.
- Regeneron Pharmaceuticals Inc. (REGN)
- Sanofi (SNY)
- Inovio Pharmaceuticals Inc. (INO)
- Moderna Inc. (MRNA)
Q: Hi folks,
In view of the coronavirus concerns, which are the companies you would recommend now as likely to grow strongly in the search for a vaccine or in the production of the equipment needed for fighting the spread of this virus ? Could you as well indicate the degree of risk involved in such companies and an order of priorities for the most interesting now ? As a start, what about GILD, INO, MRNA, REGN, SNY ?
Please deduct as many credits as you see fit.
And make sure you stay healthy…...we need you more than ever !
J. IDS
In view of the coronavirus concerns, which are the companies you would recommend now as likely to grow strongly in the search for a vaccine or in the production of the equipment needed for fighting the spread of this virus ? Could you as well indicate the degree of risk involved in such companies and an order of priorities for the most interesting now ? As a start, what about GILD, INO, MRNA, REGN, SNY ?
Please deduct as many credits as you see fit.
And make sure you stay healthy…...we need you more than ever !
J. IDS
Q: 5i Team,
I'm curious what I'm missing in analyzing GUD? They're about a week or so away from reporting the first results of the acquisition, which should start to put them at a run rate of slightly less than $300M in revenues.
They should also have, once the dust clears have about $300M in cash left.
No debt, incredible growth, and a cash hoard for another major acquisition and it trades below book?
What am I missing?
Thanks!
I'm curious what I'm missing in analyzing GUD? They're about a week or so away from reporting the first results of the acquisition, which should start to put them at a run rate of slightly less than $300M in revenues.
They should also have, once the dust clears have about $300M in cash left.
No debt, incredible growth, and a cash hoard for another major acquisition and it trades below book?
What am I missing?
Thanks!
Q: Hi there. It seems like in this Coronavirus hysteria nobody is excited about testing or treating cancer based on the trading of Guardant and Exact sciences. Do you like the current levels as a nice entry point for a speculative and long term position in each? It seems oversold unless I am missing a fundamental problem. To put a sharp point on the question, are they good buys today?
Thanks!
Thanks!
Q: i would be interested in your thoughts on this company. It had a big up Tuesday. Can it keep going?
Q: Any idea when GUD reports?
What are the market expectations?
Thanks
What are the market expectations?
Thanks
Q: Hoping this week will provide some good buying opportunities. Could you give some recommendations for a healthcare company, Canada or U.S., that pays a dividend. Preferably something with dividend growth.
Q: Thoughts on VMD's Q4 posted today?
Q: This is an emerging life science technology company, that develops and sells instruments, consumables, and software for analyzing biological systems. The story seems to be quite positive. Do you have any insights into this?
Q: Can you give your current thoughts on this company please? What is the growth outlook and how does the balance sheet look? Would you recommend anything else in the US instaed? Thank you
Q: I had hoped that GUD would have held up better in the face of the current sell-off, but so be it. Are we reaching attractive levels to add to positions in your opinion?
Thanks
Thanks
Q: Hi 5i team,
There is no much working in the market these days, which I guess is an understatement. Two stocks that are positively correlated with the virus are MRNA and GILD. There is only one dated question on MRNA. It is developing a potential vaccine for the disease. There is a recent question on GILD, but you did not mention the potential of the drug it is developing to treat people with the disease, likely due to how the question was posed. Both companies are fast-tracking their efforts. MRNA seems to have gone parabolic and hence, looks a lot more risky here. GILD was a value trap for years with a poor pipeline but seems to be breaking out now, which I attribute to the potential of the new drug, if it works.
What are your thoughts on MRNA and GILD is view of their efforts to combat the coronavirus?
Thanks again.
Dave
There is no much working in the market these days, which I guess is an understatement. Two stocks that are positively correlated with the virus are MRNA and GILD. There is only one dated question on MRNA. It is developing a potential vaccine for the disease. There is a recent question on GILD, but you did not mention the potential of the drug it is developing to treat people with the disease, likely due to how the question was posed. Both companies are fast-tracking their efforts. MRNA seems to have gone parabolic and hence, looks a lot more risky here. GILD was a value trap for years with a poor pipeline but seems to be breaking out now, which I attribute to the potential of the new drug, if it works.
What are your thoughts on MRNA and GILD is view of their efforts to combat the coronavirus?
Thanks again.
Dave
Q: Please comment on the recent earnings report.
Q: In regards to Bernie Sanders question even if he is elected president I think he will also need to get the Senate and the House of Representatives backing his proposed healthcare legislation which is far from a sure thing. Considering the difficulty Obama had in legislating the affordable health care act (AKA Obama Care) it remains to be seen how much success Mr. Sanders will achieve with his healthcare proposals. All that being said the market can and does act on emotions so a Sanders presidency could be expected to increase volatility in healthcare stocks. I agree completely with your position not to react to speculation on Mr. Sanders. I always want to ride out volatility. As an aside I doubt any one of us has read Mr. Sanders detailed proposals on health care so our opinions about his healthcare proposals are already an emotional response based on fears and sound bites...not a recipe for successful investing.
Regards,
Jim
Regards,
Jim
Q: Thoughts on UBX:US?
Q: Savaria's price seems to have reacted poorly in the "virus" market. For a health care stock this was a little surprising. Do you have any thoughts on what might be concerning investors?
Thanks
Mike
Thanks
Mike
Q: Hi 5i Team,
Pls comment on Amarin Corp ‘s earning and give your outlook of this company. Share price dropped 7% at the time of writing.
I am holding a small position, buy more, hold or sell?
Thank you for your professional advice and help as always.
Pls comment on Amarin Corp ‘s earning and give your outlook of this company. Share price dropped 7% at the time of writing.
I am holding a small position, buy more, hold or sell?
Thank you for your professional advice and help as always.
Q: I am thinking of buying this company, but was surprised to see a lot of insider sells. What do you think?
Q: Over a year since last question; what are your current thoughts please?